[11C]Flumazenil PET in Temporal Lobe Epilepsy: Do We Need an Arterial Input Function or Kinetic Modeling?
暂无分享,去创建一个
Rolf A Heckemann | Alexander Hammers | John S Duncan | Federico E Turkheimer | Wolfgang Kelsch | David J Brooks | Matthias J Koepp | F. Turkheimer | D. Brooks | J. Duncan | A. Hammers | M. Koepp | W. Kelsch | P. Panagoda | R. Heckemann | Prasan Panagoda
[1] C. Bruton,et al. The neuropathology of temporal lobe epilepsy , 1988 .
[2] Vincent J. Cunningham,et al. Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model , 1997, NeuroImage.
[3] Ivanka Savic,et al. [11C]Flumazenil Positron Emission Tomography Visualizes Frontal Epileptogenic Regions , 1995, Epilepsia.
[4] Karl J. Friston,et al. Unified segmentation , 2005, NeuroImage.
[5] O Muzik,et al. Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy , 2000, Neurology.
[6] M Vapalahti,et al. [11 C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology. , 2000, Neurology.
[7] D J Brooks,et al. Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission , 2000, Neurology.
[8] O Muzik,et al. Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome , 2001, Neurology.
[9] D J Brooks,et al. 11C-flumazenil PET in neocortical epilepsy , 1998, Neurology.
[10] O Muzik,et al. [11C]flumazenil PET: activity images versus parametric images for the detection of neocortical epileptic foci. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] W. van Paesschen,et al. Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis. , 1997, Brain : a journal of neurology.
[12] O. Muzik,et al. Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy , 1999, Neurology.
[13] V J Cunningham,et al. Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy , 2001, Neurology.
[14] François Mauguière,et al. Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: a [11C]flumazenil-PET study. , 2005, Brain : a journal of neurology.
[15] L Cinotti,et al. Parameter and index images of benzodiazepine receptor concentration in the brain. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] Alexander Hammers,et al. Periventricular White Matter Flumazenil Binding and Postoperative Outcome in Hippocampal Sclerosis , 2005, Epilepsia.
[17] M. Richardson,et al. Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients. , 2003, Brain : a journal of neurology.
[18] G. Weber-Luxenburger,et al. Interictal hippocampal benzodiazepine receptors in temporal lobe epilepsy: comparison with coregistered hippocampal metabolism and volumetry , 2000, European journal of neurology.
[19] C Crouzel,et al. Quantification of Benzodiazepine Receptors in Human Brain Using PET, [11C]Flumazenil, and a Single-Experiment Protocol , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] Adriaan A Lammertsma,et al. Population plasma pharmacokinetics of 11C-flumazenil at tracer concentrations. , 2005, British journal of clinical pharmacology.
[21] Jerome Engel,et al. Outcome with respect to epileptic seizures. , 1993 .
[22] O Muzik,et al. Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy , 2000, Neurology.
[23] F Mauguière,et al. Transient and falsely lateralizing flumazenil-PET asymmetries in temporal lobe epilepsy , 1999, Neurology.
[24] J C Froment,et al. Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. , 1998, Brain : a journal of neurology.
[25] Karl J. Friston,et al. Image registration using a symmetric prior—in three dimensions , 1999, Human brain mapping.
[26] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[27] Karl J. Friston,et al. Cerebral benzodiazepine receptors in hippocampal sclerosis. An objective in vivo analysis. , 1996, Brain : a journal of neurology.
[28] G. Franck,et al. Is 11C-flumazenil PET superior to 18FDG PET and 123I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy? , 1997, Journal of neurology, neurosurgery, and psychiatry.
[29] Effects of Metabolite Correction for Arterial Input Function on Quantitative Receptor Images With 11C-Flumazenil in Clinical Positron Emission Tomography Studies , 2004, Journal of computer assisted tomography.
[30] R. Koeppe,et al. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain , 1991, Annals of neurology.
[31] I Savic,et al. Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[32] T. Jones,et al. Spectral Analysis of Dynamic PET Studies , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[33] J. Delforge,et al. Parametric Images of Benzodiazepine Receptor Concentration Using a Partial-Saturation Injection , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[34] D E Kuhl,et al. In vivo cerebral metabolism and central benzodiazepine‐receptor binding in temporal lobe epilepsy , 1993, Neurology.
[35] D J Brooks,et al. Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI. , 2002, Brain : a journal of neurology.
[36] V J Cunningham,et al. 11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy , 1997, Neurology.
[37] G. Franck,et al. Is 11 C-flumazenil PET superior to 18 FDG PET and 1231-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy ? , 2003 .
[38] T Sasaki,et al. Intrasubject correlation between static sean and distribution volume images for [11C]flumazenil PET , 2000, Annals of nuclear medicine.
[39] K. Wienhard,et al. MRI-Guided Flumazenil- and FDG-PET in Temporal Lobe Epilepsy , 1996, NeuroImage.
[40] A Connelly,et al. The spectrum of hippocampal sclerosis: A quantitative magnetic resonance imaging study , 1997, Annals of neurology.
[41] Alexander Hammers,et al. Three‐dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe , 2003, Human brain mapping.